Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
With
Eli Lilly and Company
Age
10–16
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Treatment with diet and exercise alone or a stable dose of metformin, or sulfonylurea, or metformin plus a sulfonylurea for at least 3 months.
Has HbA1c 6.0% to 11.0%, inclusive, at screening.
Has a body weight of \>= 50 kg at screening.
You may not be if
Received any investigational drug or has participated in any type of clinical trial within 3 months prior to screening.
Currently participates in any other interventional study.
Is currently treated with any of the following excluded medications:
* Sulfonylurea chlorpropamide
* Thiazolidinedione within 3 months of screening.
* Αlpha glucosidase inhibitor within 3 months of screening.
* Meglitinide within 3 months of screening.
* Insulin within 3 months of screening.
* Pramlintide within 3 months of screening.
Clareo Health | A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Tolerability of Exenatide in Adolescent Subjects With Type 2 Diabetes Mellitus
